Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men

Edward W. Hook, William M. McCormack, David Martin, Robert B. Jones, Karen Bean, Allan N. Maroli, H. Hunter Handsfield, John M. Douglas, Jonathan Mark Zenilman, Peter Leone, Peter Rice

Research output: Contribution to journalArticle

Abstract

In a randomized open study, 351 male patients with uncomplicated gonorrhea were given single oral doses of grepafloxacin (400 mg) or cefixime (400 mg). In the 299 microbiologically evaluable patients, urethral infections were cured in 99% (147 of 149) of those receiving grepafloxacin and 97% (145 of 150) of those given cefixime. Eradication rates for both regimens were 100% in the 16% (47 of 299) of participants who were infected with penicillin-resistant Neisseria gonorrhoeae and 97% in the 21% (62 of 299) of participants infected with tetracycline-resistant strains. Grepafloxacin is a well-tolerated alternative to cefixime for treatment of uncomplicated gonorrhea in males.

Original languageEnglish (US)
Pages (from-to)1843-1845
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume41
Issue number8
StatePublished - Aug 1997

Fingerprint

Cefixime
Gonorrhea
Neisseria gonorrhoeae
Tetracycline
Penicillins
Therapeutics
Infection
grepafloxacin

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Hook, E. W., McCormack, W. M., Martin, D., Jones, R. B., Bean, K., Maroli, A. N., ... Rice, P. (1997). Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. Antimicrobial Agents and Chemotherapy, 41(8), 1843-1845.

Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. / Hook, Edward W.; McCormack, William M.; Martin, David; Jones, Robert B.; Bean, Karen; Maroli, Allan N.; Handsfield, H. Hunter; Douglas, John M.; Zenilman, Jonathan Mark; Leone, Peter; Rice, Peter.

In: Antimicrobial Agents and Chemotherapy, Vol. 41, No. 8, 08.1997, p. 1843-1845.

Research output: Contribution to journalArticle

Hook, EW, McCormack, WM, Martin, D, Jones, RB, Bean, K, Maroli, AN, Handsfield, HH, Douglas, JM, Zenilman, JM, Leone, P & Rice, P 1997, 'Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men', Antimicrobial Agents and Chemotherapy, vol. 41, no. 8, pp. 1843-1845.
Hook EW, McCormack WM, Martin D, Jones RB, Bean K, Maroli AN et al. Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. Antimicrobial Agents and Chemotherapy. 1997 Aug;41(8):1843-1845.
Hook, Edward W. ; McCormack, William M. ; Martin, David ; Jones, Robert B. ; Bean, Karen ; Maroli, Allan N. ; Handsfield, H. Hunter ; Douglas, John M. ; Zenilman, Jonathan Mark ; Leone, Peter ; Rice, Peter. / Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. In: Antimicrobial Agents and Chemotherapy. 1997 ; Vol. 41, No. 8. pp. 1843-1845.
@article{51888372828d414fa5d74ce37b929114,
title = "Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men",
abstract = "In a randomized open study, 351 male patients with uncomplicated gonorrhea were given single oral doses of grepafloxacin (400 mg) or cefixime (400 mg). In the 299 microbiologically evaluable patients, urethral infections were cured in 99{\%} (147 of 149) of those receiving grepafloxacin and 97{\%} (145 of 150) of those given cefixime. Eradication rates for both regimens were 100{\%} in the 16{\%} (47 of 299) of participants who were infected with penicillin-resistant Neisseria gonorrhoeae and 97{\%} in the 21{\%} (62 of 299) of participants infected with tetracycline-resistant strains. Grepafloxacin is a well-tolerated alternative to cefixime for treatment of uncomplicated gonorrhea in males.",
author = "Hook, {Edward W.} and McCormack, {William M.} and David Martin and Jones, {Robert B.} and Karen Bean and Maroli, {Allan N.} and Handsfield, {H. Hunter} and Douglas, {John M.} and Zenilman, {Jonathan Mark} and Peter Leone and Peter Rice",
year = "1997",
month = "8",
language = "English (US)",
volume = "41",
pages = "1843--1845",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men

AU - Hook, Edward W.

AU - McCormack, William M.

AU - Martin, David

AU - Jones, Robert B.

AU - Bean, Karen

AU - Maroli, Allan N.

AU - Handsfield, H. Hunter

AU - Douglas, John M.

AU - Zenilman, Jonathan Mark

AU - Leone, Peter

AU - Rice, Peter

PY - 1997/8

Y1 - 1997/8

N2 - In a randomized open study, 351 male patients with uncomplicated gonorrhea were given single oral doses of grepafloxacin (400 mg) or cefixime (400 mg). In the 299 microbiologically evaluable patients, urethral infections were cured in 99% (147 of 149) of those receiving grepafloxacin and 97% (145 of 150) of those given cefixime. Eradication rates for both regimens were 100% in the 16% (47 of 299) of participants who were infected with penicillin-resistant Neisseria gonorrhoeae and 97% in the 21% (62 of 299) of participants infected with tetracycline-resistant strains. Grepafloxacin is a well-tolerated alternative to cefixime for treatment of uncomplicated gonorrhea in males.

AB - In a randomized open study, 351 male patients with uncomplicated gonorrhea were given single oral doses of grepafloxacin (400 mg) or cefixime (400 mg). In the 299 microbiologically evaluable patients, urethral infections were cured in 99% (147 of 149) of those receiving grepafloxacin and 97% (145 of 150) of those given cefixime. Eradication rates for both regimens were 100% in the 16% (47 of 299) of participants who were infected with penicillin-resistant Neisseria gonorrhoeae and 97% in the 21% (62 of 299) of participants infected with tetracycline-resistant strains. Grepafloxacin is a well-tolerated alternative to cefixime for treatment of uncomplicated gonorrhea in males.

UR - http://www.scopus.com/inward/record.url?scp=8544225736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8544225736&partnerID=8YFLogxK

M3 - Article

C2 - 9257777

AN - SCOPUS:8544225736

VL - 41

SP - 1843

EP - 1845

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -